City

Boston (1)

Charlottesville (1)

Jacksonville (1)

New York (1)

Rochester (1)

Scottsdale (1)

Seattle (1)

Condition

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma (1)

Central Nervous System Lymphoma (1)

Intraocular Lymphoma (1)

Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System (1)

Recurrent Adult Diffuse Large Cell Lymphoma (1)

Retinal Lymphoma (1)

Overall Status

Completed (1)

Phase

phase 1 (1)

Sponsor

Mayo Clinic (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

dexamethasone (1)

laboratory biomarker analysis (1)

pharmacological study (1)

pomalidomide (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (1)

Study Type

Interventional (1)

retinal lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Burkitt Lymphoma, CNS Lymphoma, Intraocular

Completed

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
+5 more

Dexamethasone
+3 more

Scottsdale, Arizona
+6 more

Jul 18, 2019